Prognostický význam hyperdiploidie/non-hyperdiploidie u souboru 74 relabovaných pacientů s mnohočetným myelomem léčených bortezomibem a thalidomidem

Warning

This publication doesn't include Faculty of Arts. It includes Faculty of Science. Official publication website can be found on muni.cz.

Title in English	Prgonostic significance of hyperdiploidy/non-hyperdiplidy of cohort of 74 replapsed patients with multiple myeloma treated by bortezomib and thalidomide
Authors	SMETANA Jan KUGLÍK Petr GREŠLIKOVÁ Henrieta NĚMEC Pavel ZAORALOVÁ Romana KUPSKÁ Renata FILKOVÁ Hana POUR Luděk KREJČÍ Marta ZAHRADOVÁ Lenka HOLÁNEK Michal ADAM Zdeněk NEČASOVÁ Jana HÁJEK Roman
Year of publication	2008
Type	Conference abstract
MU Faculty or unit	Faculty of Science
Citation
Description	We focus on the applications of immunofluorescent staining of tumor plasma cells and three-color interphase in situ hybridization with specific DNA probes for chromosome 5, 9, and 15 for the detection of hyperdiploidy in patients with multiple myeloma.
Related projects:	Molecular basis of cell and tissue regulations University Research Centre - Czech Myeloma Group From classic prognostic markers to clinical applications in selected pharmacogenomic and pharmacoproteomic projects in multiple myeloma and monoclonal gammapathies